tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ABUS Stock Latest News

Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
13d ago
ABUS
ALDX
Arbutus Biopharma price target raised to $7 from $5 at Jefferies
PremiumThe Fly
Arbutus Biopharma price target raised to $7 from $5 at Jefferies
14d ago
PFE
ABUS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
14d ago
ABUS
APTO
Arbutus Biopharma Engages Investors at Key Conferences
PremiumCompany Announcements
Arbutus Biopharma Engages Investors at Key Conferences
16d ago
ABUS
Arbutus to Participate in Two Upcoming Investor Conferences
PremiumPress Releases
Arbutus to Participate in Two Upcoming Investor Conferences
16d ago
ABUS
Arbutus Biopharma and Moderna Agree to Delay Patent Trial
PremiumCompany AnnouncementsArbutus Biopharma and Moderna Agree to Delay Patent Trial
2M ago
8K
ABUS
Arbutus Biopharma’s Promising Hepatitis B Drug Trials
Premium
Company Announcements
Arbutus Biopharma’s Promising Hepatitis B Drug Trials
2M ago
ABUS
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Premium
Press Releases
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
2M ago
ABUS
Arbutus Biopharma reports Q2 EPS (11c), consensus (10c)
PremiumThe Fly
Arbutus Biopharma reports Q2 EPS (11c), consensus (10c)
2M ago
ABUS
Is ABUS a Buy, Before Earnings?
PremiumPre-Earnings
Is ABUS a Buy, Before Earnings?
2M ago
ABUS
Arbutus Biopharma Sets Q2 2024 Financial Results Date
PremiumCompany Announcements
Arbutus Biopharma Sets Q2 2024 Financial Results Date
2M ago
ABUS
Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
PremiumPress Releases
Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
2M ago
ABUS
Arbutus Reports Promising Hepatitis B Trial Results
PremiumCompany AnnouncementsArbutus Reports Promising Hepatitis B Trial Results
4M ago
ABUS
Barinthus presents EOT data from Phase 2a trial of imdusiran, VTP-300
Premium
The Fly
Barinthus presents EOT data from Phase 2a trial of imdusiran, VTP-300
4M ago
ABUS
BRNS
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
Premium
Press Releases
Treatment with Arbutus’ Imdusiran and VTP-300 Achieves Statistical Significance in Lowering HBsAg Levels
4M ago
ABUS
Arbutus announces preliminary EOT data from Phase 2a trial of imdusiran, VTP-300
PremiumThe Fly
Arbutus announces preliminary EOT data from Phase 2a trial of imdusiran, VTP-300
4M ago
ABUS
BRNS
Arbutus Biopharma’s Promising HBV Treatment Data
PremiumCompany Announcements
Arbutus Biopharma’s Promising HBV Treatment Data
4M ago
ABUS
Arbutus Biopharma announces new data from IM-PROVE trial
PremiumThe Fly
Arbutus Biopharma announces new data from IM-PROVE trial
4M ago
ABUS
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
PremiumPress Releases
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
4M ago
ABUS
Arbutus to Participate in Jefferies Global Healthcare Conference
PremiumPress ReleasesArbutus to Participate in Jefferies Global Healthcare Conference
4M ago
ABUS
Arbutus Biopharma Shareholders Approve Board Changes and Plan Expansion
Premium
Company Announcements
Arbutus Biopharma Shareholders Approve Board Changes and Plan Expansion
4M ago
8K
ABUS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
PFE
VIR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >